• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Letter: association between COVID-19 and inflammatory bowel disease-Authors' reply.信函：2019冠状病毒病与炎症性肠病之间的关联——作者回复
Aliment Pharmacol Ther. 2022 May;55(9):1228-1229. doi: 10.1111/apt.16900.
2
Letter: paying attention to the comorbidities or extraintestinal complications in patients with inflammatory bowel disease during the COVID-19 pandemic-authors' reply.信：在 COVID-19 大流行期间关注炎症性肠病患者的合并症或肠外并发症——作者的回复。
Aliment Pharmacol Ther. 2022 Jul;56(1):178. doi: 10.1111/apt.16977.
3
Letter: inflammatory bowel disease services during the Covid-19 pandemic - authors' reply.信件：Covid-19 大流行期间的炎症性肠病服务-作者回复。
Aliment Pharmacol Ther. 2022 Apr;55(8):1064. doi: 10.1111/apt.16884.
4
Letter: COVID-19 outcomes and anti-TNF treatments-comprehensive evidence matters. Authors' reply.信件：2019冠状病毒病的结局与抗TNF治疗——全面的证据很重要。作者回复。
Aliment Pharmacol Ther. 2022 May;55(9):1235-1236. doi: 10.1111/apt.16904.
5
Editorial: COVID-19 vaccines are safe and effective in patients with inflammatory bowel disease-but many unanswered questions remain. Authors' reply.社论：COVID-19 疫苗在炎症性肠病患者中安全有效——但仍有许多未解答的问题。作者回复。
Aliment Pharmacol Ther. 2022 Jul;56(1):164-165. doi: 10.1111/apt.16976.
6
Letter: SARS-CoV-2 infection in two inflammatory bowel disease patients treated with dual targeted therapy-Authors' reply.信：接受双重靶向治疗的两位炎症性肠病患者的 SARS-CoV-2 感染情况-作者答复。
Aliment Pharmacol Ther. 2021 Mar;53(6):766-767. doi: 10.1111/apt.16287.
7
Letter: pancreatic involvement in inflammatory bowel disease-authors' reply.信函：炎症性肠病中的胰腺受累——作者回复。
Aliment Pharmacol Ther. 2022 Jul;56(2):371. doi: 10.1111/apt.17082.
8
Letter: IBD nurse-pivotal role in the time of the pandemic. Authors' reply.信件：炎症性肠病护士在疫情期间的关键作用。作者回复。
Aliment Pharmacol Ther. 2020 Aug;52(4):746-747. doi: 10.1111/apt.15954.
9
Letter: the effect of anti-COVID-19 treatment on the outcome of patients with inflammatory bowel disease-authors' reply.信件：抗 COVID-19 治疗对炎症性肠病患者结局的影响-作者答复。
Aliment Pharmacol Ther. 2022 Jul;56(1):179. doi: 10.1111/apt.16978.
10
Authors' Reply to: 'COVID-19 in the IBD Population: The Need for Correct Nomenclature'.作者对《炎症性肠病患者中的COVID-19：正确命名的必要性》的回复
J Crohns Colitis. 2021 Jun 22;15(6):1080. doi: 10.1093/ecco-jcc/jjaa240.

本文引用的文献

1
Letter: association between COVID-19 and inflammatory bowel disease.信件：COVID-19 与炎症性肠病之间的关联。
Aliment Pharmacol Ther. 2022 May;55(9):1226-1227. doi: 10.1111/apt.16814.
2
Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: propensity matched research network analysis.新型冠状病毒肺炎对炎症性肠病的发病率、结局及影响：倾向匹配研究网络分析
Aliment Pharmacol Ther. 2022 Jan;55(2):191-200. doi: 10.1111/apt.16730. Epub 2021 Dec 14.
3
Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease.炎症性肠病患者对新型冠状病毒mRNA疫苗的体液免疫反应
Gastroenterology. 2021 Oct;161(4):1340-1343.e2. doi: 10.1053/j.gastro.2021.06.016. Epub 2021 Jun 15.
4
COVID-19 vaccinations in patients with inflammatory bowel disease.炎症性肠病患者的新冠病毒疫苗接种
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):965-966. doi: 10.1016/S2468-1253(20)30295-8. Epub 2020 Sep 21.
5
Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.在瑞典，60 岁及以上被诊断为炎症性肠病患者的发病率和治疗方法。
Gastroenterology. 2018 Feb;154(3):518-528.e15. doi: 10.1053/j.gastro.2017.10.034. Epub 2017 Nov 2.
6
Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG).在瑞典国家患者登记册和瑞典炎症性肠病质量登记册（SWIBREG）中验证炎症性肠病（IBD）。
Scand J Gastroenterol. 2017 Feb;52(2):216-221. doi: 10.1080/00365521.2016.1246605. Epub 2016 Oct 31.

信函：2019冠状病毒病与炎症性肠病之间的关联——作者回复

Letter: association between COVID-19 and inflammatory bowel disease-Authors' reply.

作者信息

Hadi Yousaf, Kochhar Gursimran S

机构信息

Department of Gastroenterology & Hepatology, West Virginia University, Morgantown, West Virginia, USA.

Department of Gastroenterology & Hepatology, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.

出版信息

Aliment Pharmacol Ther. 2022 May;55(9):1228-1229. doi: 10.1111/apt.16900.

DOI:10.1111/apt.16900
PMID:35429037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9111504/
Abstract

This article is linked to Hadi et al papers. To view these articles, visit https://doi.org/10.1111/apt.16730 and https://doi.org/10.1111/apt.16814

摘要

本文与哈迪等人的论文相关联。要查看这些文章，请访问https://doi.org/10.1111/apt.16730和https://doi.org/10.1111/apt.16814